1,25-Dihydroxyvitamin D3 and the Immune System

Proceedings of the Society for Experimental Biology and Medicine

Volumn 191, Issue 3, 1989, Pages 238-245

  Manolagas, Stavros C ^a   Hustmyer, Frank G ^a   yu, Xiao Peng ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIHYDROXYCOLECALCIFEROL; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 2; RECEPTOR;

ANIMAL CELL; B LYMPHOCYTE; CATTLE; CELL CULTURE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMOCYTE;

ANIMAL; CALCITRIOL; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; LYMPHOKINES; RECEPTORS, CALCITRIOL; RECEPTORS, STEROID; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024399353     PISSN: 00379727     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/00379727-191-42915     Document Type: Article

References (78)

1. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-Dihydroxy vitamin D3 receptors in human leukocytes. Science 221:1181-1183, 1983.
2. Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57:1308-1310, 1983.
3. Rossi JF, Dune BGM, Duperray C, Braich T, Marion SL, Pike JW, Haussler MR, Janbon C, Bataille R. Phenotypic and functional analysis of 1,25-dihydroxyvitamin D3 receptor mediated modulation of the human myeloma cell line RPMI 8226. Cancer Res 48:1213-1216, 1988.
4. Nunn JD, Katz DR, Barker S, Fraher LJ, Hewison M, Hendy GN, O'Riordan JL. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology 59:479-484, 1986.
5. 3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J Clin Endocrinol Metab 68:774-779, 1989.
6. 3-binding macromolecules in human B lymphocytes: Effects on immunoglobulin production. J Immunol 136:2734-2740, 1986.
7. Manolagas SC, Provvedini DM, Murray EJ, Tsoukas CD, Deftos LJ. The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells. J Clin Endocrinol Metab 63:394-400, 1986.
8. Manolagas SC, Werntz DA, Tsoukas CD, Provvedini DM, Vaughan JH. 1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis. J Lab Clin Med 108:596-600, 1986.
9. Provvedini DM, Rulot CM, Sobol RE, Tsoukas CD, Manolagas SC. 1α,25-Dihydroxyvitamin D3 Receptors in Human Thymic and Tonsillar Lymphocytes. J Bone Miner Res 2:239-247, 1987.
10. Koren R, Ravid A, Liberman UA, Hochberg Z, Weisman Y, Novogrodsky A. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D. J Clin Invest 76:2012-2015, 1985.
11. Takeda E, Kuroda Y, Saijo T, Toshima K, Naito E, Kobashi H, Iwakuni Y, Miyao M. Rapid diagnosis of vitamin D-dependent rickets type II by use of phytohemagglutinin-stimulated lymphocytes. Clin Chim Acta 155:245-250, 1986.
12. Provvedini DM, Deftos LJ, Manolagas SC. 1,25-Dihydroxyvitamin D3 receptors in a subset of mitotically active lymphocytes from rat thymus. Biochem Biophys Res Commun 121:277-283, 1984.
13. Ravid A, Koren R, Novogrodsky A, Liberman UA, 1,25-Dihydroxyvitamin D3 inhibits selectively the mitogenic stimulation of mouse medullary thymocytes. Biochem Biophys Res Commun 123:163-169, 1984.
14. Provvedini DM, Sakagami Y, Manolagas SC. Distinct target cells and effects of 1α,25-dihydroxyvitamin D3 and glucocorticoids in the rat thymus g. Endocrinology 124: 1532-1538, 1989.
15. Manolagas SC, Provvedini DM, Murray EJ, Murray SS, Tsonis PA, Spandidos DA. Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 84:856-860, 1987.
16. Manolagas SC, Provvedini DM, Tsoukas CD. Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 43:113-122, 1985.
17. Rigby W. The immunobiology of vitamin D. Immunol Today 9:54-58, 1988.
18. Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxyvitamin D3: A novel immunoregulatory hormone. Science 224:1438-1440, 1984.
19. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74:1451-1455, 1984.
20. Rigby WF, Noelle RJ, Krause K, Fanger MW. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: A cell cycle analysis. J Immunol 135:2279-2286,1985.
21. 3: Cellular requirements and mechanisms. In: Norman AW, Schaefer K, Grigoleit HG, Herrath Dv, Eds. Vitamin D: Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, p 282, 1988.
22. Doherty CC, LaBelle P, Collins JF, Brautbar N, Massry SG. Effect of parathyroid hormone on random migration of human polymorphonuclear leukocytes. Am J Nephrol 8:212-219, 1988.
23. Zarrabeitia MT, Riancho JA, Rodriguez-Valverde V, Farinas MC, Gonzalez-Macias J. Role of monocytes in the inhibitory effect of calcitriol on PHA-stimulated lymphocytes. Blut 54:343-349, 1987.
24. Hodler B, Evequoz V, Trechsel U, Fleisch H, Stadler B. Influence of vitamin D3 metabolites on the production of interleukins 1, 2 and 3. Immunobiology 170:256-269, 1985.
25. Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 98:311-322, 1986.
26. Amento EP, Bhalla AK, Kurnick JT, Kradin RL, Clemens TL, Holick SA, Holick MF, Krane SM. 1 alpha, 25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest 73:731-739, 1984.
27. Hoshino T, Iho S, Kura F. Effect of 1,25-dihydroxyvitamin D3 on the immunocompetent cells. Methods Exp Clin Pharmacol 8:167-173, 1986.
28. Kurt-Jones EA, Beller DI, Mizel SB, Unanue ER. Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci USA 82:1204-1208, 1985.
29. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134:3032-3035, 1985.
30. Lacey DL, Axelrod J, Chappel JC, Kahn AJ, Teitelbaum SL. Vitamin D affects proliferation of a murine T helper cell clone. J Immunol 138:1680-1686, 1987.
31. Hustmyer FG, Nonnecke BJ, Beitz DC, Horst RL, Reinhardt TA. 1,25-Dihydroxyvitamin D3 enhancement of concanavalin-A induced bovine lymphocyte proliferation: Requirement of monocytes, Biochem Biophys Res Commun 152:545-551, 1988.
32. Haverty T, Haddad JG, Neilson EG. 1,25-Dihydroxyvitamin D3 stimulates interleukin-2 production by a T cell lymphoma line (MLA-144) cultured in vitamin D-deficient rat serum. J Leukocyte Biol 41:177-182, 1987.
33. Nakao Y, Koizumi T, Matsui T, Matsuda S, Nakagawa T, Katakami Y, Fujita T, Maeda S, Morikawa S, Ito Y. Effect of 1a, 25-dihydroxyvitamin D3 on proliferation of activated T-cells and established human lymphotropic virus type 1-positive T-cell lines. J Natl Can Inst 78:1079-1086, 1987.
34. Reichel H, Koeffler HP, Tobler A, Norman AW. 1α,25-Dihydroxyvitamin D3 inhibits 7-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 84:3385-3389, 1987.
35. Tobler A, Gasson J, Reichel H, Norman AW, Koeffler HP. Granulocyte-macrophage colony-stimulating factor. J Clin Invest 79:1700-1705, 1987.
36. Rigby WFC, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. J Clin Invest 79:1659-1664, 1987.
37. Matsui T, Takahashi R, Nakao Y, Koizumi T, Katakami Y, Mihara K, Sugiyama T, Fujita T. 1,25-Dihydroxyvitamin D3-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation. Cancer Res 46:5827-5831, 1986.
38. Tobler A, Miller C, Norman AW, Koeffler HP. 1,25-Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally. J Clin Invest 81:1819-1823, 1988.
39. 3. J Immunol 136:2181-2186, 1986.
40. 3. Cancer Res 45:4366-4371, 1985.
41. Chihara K, Fujita T, Shiozawa S. Radioimmunoassay of plasma interferon-a in osteoporosis. Calcif Tissue Int 42:A42, 1985.
42. Lemire JM, Adams JS, Sakai R, Jordan SC. 1,25-Dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657-661, 1984.
43. Haq AU. 1,25-Dihydroxyvitamin D3 (calcitriol) suppresses IL-2 induced murine thymocyte proliferation. Thymus 8:295-306, 1986.
44. Provvedini DM, Deftos LJ, Manolagas SC. 1,25-Dihydroxyvitamin D3 promotes in vitro morphologic and enzymatic changes in normal human monocyte consistent with their differentiation into macrophages. Bone 7:23-28, 1986.
45. Abe E., Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T. Differentiation of mouse myeloid leukemia cells induced by 1a, 25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78:4990-4994, 1981.
46. Suda T, Miyaura C, Abe E, Kuroki T. Modulation of cell differentiation, Immune responses and tumor promotions by vitamin D compounds. Bone Miner Res 4:1-48, 1986.
47. Reitsma PH, Rothberg PG, Astrin SM, Trial J, Bar-Shavit Z, Hall A, Teitelbaum SL, Kahn AJ. Regulation of myc gene expression in HL-60 leukemia cells by a vitamin D metabolite. Nature 306:492-494, 1983.
48. 3 and its fluorinated analogues. Cancer Res 44:5624-5628, 1984.
49. Amento EP, Cotter AC. 1,25-Dihydroxyvitamin D3 augments antigen presentation by murine monocyte/macrophages. J Bone Min Res 3:S217, 1988.
50. Rook GAW, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J, Stanford J. Vitamin D3, gamma interferon, and control of proliferation of mycobacterium tuberculosis by human monocytes. Immunology 57:159-163, 1986.
51. Cohen MS, Mesler DE, Snipes RG, Gray TK. 1,25-Dihydroxyvitamin D3 activates secretion of hydrogen peroxide by human monocytes. J Immunol 136:1049-1053, 1986.
52. Polla BS, Healy AM, Amento EP, Krane SM. 1,25-Dihydroxyvitamin D3 maintains adherence of human monocytes and protects them from thermal injury. J Clin Invest 77:1332-1339, 1986.
53. Bar-Shavit Z, Noff D, Edelstein S, Meyer M, Shibolet S, Goldman R. 1,25-Dihydroxyvitamin D3 and the regulation of macrophage function. Calcif Tissue Int 33:673-676, 1981.
54. Manolagas SC, Deftos LJ. The vitamin D endocrine system and the hematolymphopoietic tissue. Ann Intern Med 100:144-146, 1984.
55. Davies PDO. A possible link between vitamin D deficiency and impaired host defence to mycobacterium tuberculosis. Tubercle 66:301-306, 1985.
56. Ohsugi Y, Nakano T, Komori T, Ueno K, Sugawara Y, Fukushima M, Yamamoto T, Nishii Y, Masuda T, Matsuno M. Effect of 1α-hydroxyvitamin D3 on the immune response. In: Norman AW, Schaefer K, Grigoleit H-G, Herrath Dv, Eds. Vitamin D: A Chemical, Biochemical and Clinical Update. Berlin: Walter de Gruyter, p 209, 1985.
57. Okano K, Kou S, Shimizu M, Nozawa Y, Kato T, Yamada Y, Nawa C, Ohira K, Shinagawa N, Yajima M, Someya K. Effect of active vitamin D3 on human immune function in vivo. In: Norman AW, Schaefer K, Grigoleit H-G, Herrath Dv, Eds. Vitamin D: A Chemical, Biochemical and Clinical Update. Berlin: Walter de Gruyter, p 717, 1985.
58. Tabata T, Suzuki R, Kikunami K, Matsushita Y, Inoue Takashi, Inoue Takayuki, Okamoto T, Miki T, Nishizawa Y, Morii H. The effect of 1α-hydroxyvitamin D3 on cell-mediated immunity in hemodialyzed patients. J Clin Endocrinol Metab 63:1218-1221, 1986.
59. Fujita T, Matsui T, Nakao Y, Watanabe S. T lymphocyte subsets in osteoporosi. Effect of 1-alpha hydroxyvitamin D3. Miner Electrolyte Metab 10:375-378, 1984.
60. DeLuca HF, Ostrem VK. Analogs of the hormonal form of vitamin D and their possible use in leukemia. Nutrition, Growth and Cancer. New York: Alan R. Liss, Inc., p 41, 1988.
61. Svenson M, Muller K, Bendtzen K. 1α,25-Dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro. Immunol Lett 17:361-366, 1988.
62. Yukioka K, Otani S, Matsui-Yuasa I, Goto H, Morisawa S, Okuno S, Inaba M, Nishizawa Y, Morii H. Biological activity of 26,26,26,27,27,27-hexafluorinated analogs of vitamin D3 in inhibiting interleukin-2 production by peripheral blood mononuclear cells stimulated by phytohemagglutinin. Arch Biochem Biophys 260:45-50, 1988.
63. Binderup L, Bramm E. Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmcol 37:889-895, 1988.
64. Abe J, Morikawa M, Takita Y, Miyamoto K, Kaiho S, Fukushima M, Miyaura C, Abe E, Suda T, Nishii Y. 1α,25-Dihyroxy-22-oxavitamin D3: A new synthetic analogue of vitamin D3 having potent differentiation-inducing activity without inducing hypercalcemia in vivo and in vitro. Vitamin D. Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, p 310, 1988.
65. Muller K, Svenson M, Bendtzen K. 1α,25-Dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro. Immunol Lett 17:361-366, 1988.
66. Koeffler HP, Reichel H, Bishop JE, Norman AW. Gamma-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun 127:596-603, 1985.
67. Mudde AH, Van Den Berg H, Boshuis PG, Breedveld FC, Markusse HM, Kluin PM, Bijvoet OL, Papapoulos SE. Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia. Cancer 59:1543-1546, 1987.
68. 3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J Clin Endocrinol Metab 64;1:1-9, 1987.
69. Ishizuka S, Matsui T, Nakao Y, Fujita T, Okabe T, Fujisawa M, Watanabe J, Takaku F, Bishop JE, Reichel H, Norman AW. Metabolism of 25-dihydroxycholecalciferol in human promyelocytic leukemia cells (HL-60). Eur J Biochem 161:233-239, 1986.
70. Koeffler HP, Reichel H, Bishop JE, Norman AW. Gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun 127:596-603, 1985.
71. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 305:440-443, 1981.
72. Maesaka JK, Batuman V, Pablo NC, Shakamuri S. Elevated 1,25-dihydroxyvitamin D levels. Occurrence with sarcoidosis with end-stage renal disease. Arch Intern Med 142:1206-1207, 1982.
73. 3 in sarcoidosis and absorptive hypercalciuria: Different response to prednisolone therapy. J Clin Endocrinol Metab 51:381-386, 1980.
74. Reinhardt TA, Hustmyer FG. Role of vitamin D in the immune system. J Dairy Sci 70:952-962, 1987.
75. Rigby WFC, Yirinec B, Oldershaw RL, Fanger MW. Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur J Immunol 17:563-566, 1987.
76. Shiozawa K, Shiozawa S, Shimizu S, Fujita T. 1 alpha, 25-dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: An analysis using serum-free culture conditions. Immunology 56:161-167, 1985.
77. Iho S, Takahashi T, Kura F, Sugiyama H, Hoshino T. The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J Immunol 136:4427-4431, 1986.
78. Bhalla AK, Amento EP, Serog B., Glimcher LH. 1,25-dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 133:1748-1754, 1984.